5-Chloro-2-Methyl-1,3-Benzothiazole

Synthetic Route to 2-(Substituted Mercapto)-5-Chloro-1,3-Benzothiazole Accelerators in Sulfur-Cured Elastomer Systems

In the production of delayed-action sulfenamide accelerators, 5-Chloro-2-methyl-1,3-benzothiazole serves as the heterocyclic backbone for thiol substitution at the 2-position. The methyl group at the 2-methyl position is first oxidized to a carboxylic acid intermediate using chromic acid in sulfuric acid at 55–60°C, a step requiring precise temperature control to avoid decarboxylation. Subsequent conversion to the 2-mercapto derivative via reaction with sodium hydrosulfide under pressure in a Hastelloy C-276 autoclave at 120°C and 0.5 MPa yields the active thiol form. This intermediate is then oxidatively coupled with cyclohexylamine or tert-butylamine in the presence of sodium hypochlorite at pH 9.5–10.0 to produce N-cyclohexyl-5-chloro-2-benzothiazolesulfenamide (abbreviated CBS-Cl in internal technical bulletins from major accelerator manufacturers). The typical charge ratio for the oxidative coupling step is 1.05 mol of amine per 1.00 mol of mercaptobenzothiazole, with the slight excess amine ensuring complete consumption of the thiol and preventing disulfide formation. On production-scale equipment — typically a 5000 L glass-lined reactor with a retreat-curve impeller operating at 85 rpm tip speed — the critical processing parameter is the sodium hypochlorite feed rate, which must not exceed 0.12 L/min per 1000 L batch volume to prevent localized over-oxidation to the sulfonamide derivative. Finished CBS-Cl accelerator, when incorporated into natural rubber / butadiene rubber (NR/BR) truck tire tread compounds at 0.6–0.9 phr alongside 2.5 phr sulfur, produces a scorch time (t_s2) at 135°C of 8.2–9.5 minutes as measured per ISO 3417:2008 with a Monsanto MDR 2000E rheometer, offering a processing safety margin approximately 15% longer than the non-chlorinated parent compound. The electron-withdrawing chlorine substituent reduces the nucleophilicity of the benzothiazole nitrogen, moderating the rate of sulfur-sulfenamide cleavage and thus delaying the onset of crosslinking. This property is particularly valued in radial tire belt compounds requiring extended flow periods during calendering operations.

What Oxidative Coupling Conditions Maximize 4-Chloro-2-Methylbenzothiazole-Derived Azo Disperse Dye Yield?

5-Chloro-2-methyl-1,3-benzothiazole undergoes diazotization of the 2-amino derivative (obtained via nitration of the 2-methyl compound followed by selective reduction) to form diazonium salts that serve as electrophilic coupling components for N,N-disubstituted aniline coupling partners. In a representative protocol for C.I. Disperse Blue 183 analogs, the diazotization is conducted by dissolving the 2-amino-5-chloro-1,3-benzothiazole (1.0 molar equivalent) in 85% phosphoric acid at 0–5°C, followed by slow addition of nitrosylsulfuric acid (40% in sulfuric acid, 1.02 molar equivalents) over 90 minutes. The resulting diazonium solution is held at 0–5°C for an additional 45 minutes before being introduced dropwise into a chilled coupling bath containing N-ethyl-N-(2-cyanoethyl)aniline dissolved in a mixture of methanol, water, and sulfamic acid at pH 3.5–4.0. The coupling pH is maintained automatically via a PID-controlled metering pump adding 20% sodium acetate solution; deviations exceeding ±0.3 pH units result in significant yield losses to diazo decomposition products. Following coupling, the crude dye is isolated by filtration on a plate-and-frame press, washed to neutral conductivity with deionized water, and dried in a vacuum paddle dryer at 80°C and −0.09 MPa (gauge) until moisture content falls below 0.5%. The dried presscake is then milled in a fluid-energy mill (micronizer) with compressed air at 0.7 MPa to achieve a particle size distribution where D90 < 2.0 μm as measured by laser diffraction per ISO 13320:2020. The introduction of the 5-chloro substituent on the benzothiazole ring shifts the λ_max bathochromically by approximately 15–22 nm relative to the unchlorinated parent structure in acetone solution, moving the shade from a red-blue to a greener navy when applied to polyester fiber at 130°C under high-temperature exhaust dyeing conditions in a Thies jet-dye machine using a liquor ratio of 10:1. Fastness to sublimation evaluated per ISO 105-P01:1993 at 180°C for 30 seconds registers Grade 4–5 on the grey scale, qualifying the dye for automotive interior polyester fabrics meeting OEM specifications for lightfastness exceeding 200 hours per ISO 105-B02:2014 Xenon arc testing at Stage 7.

Production-scale diazotization in a continuous-flow microreactor system — specifically a Corning Advanced-Flow G1 glass reactor with 10 heat-exchange modules each providing 2.0 m² of surface area — has been adopted by at least two major dye manufacturers in Zhejiang, China, to replace conventional batch vessels. The process operates with a residence time of 22 seconds for the diazotization step at 5°C, compared to 90 minutes in batch mode, while achieving a Stevens-Bamfield assay of 97.8% on the diazonium salt intermediate. This technique eliminates the need for the large hold-up volumes that pose a thermal runaway hazard if the batch cooling system fails, a failure mode documented in a publicly available incident report from a Gujarat, India, dye plant in 2018 that resulted in a critical decomposition event when the jacket temperature rose above 12°C during diazonium salt hold.

Chlorinated Benzothiazole Pharmacophore in CNS-Penetrant Histamine H3 Receptor Inverse Agonists

Preclinical medicinal chemistry programs targeting the histamine H3 receptor (H3R) have extensively utilized 5-Chloro-2-methyl-1,3-benzothiazole as a privileged scaffold for constructing inverse agonists with balanced lipophilicity and high brain-to-plasma concentration ratios. The core is typically functionalized at the 2-methyl position via bromination with N-bromosuccinimide (NBS) and benzoyl peroxide (BPO) initiation in refluxing carbon tetrachloride, yielding 2-bromomethyl-5-chloro-1,3-benzothiazole in 68–74% isolated yield after recrystallization from isopropanol. This benzylic bromide is then alkylated with 1-(piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one in the presence of potassium carbonate in acetonitrile at 60°C for 18 hours to install the imidazolidinone pharmacophore. Residual genotoxic bromomethyl impurity is controlled to below 3.0 ppm as specified under the ICH M7(R1) guideline for a permitted daily exposure of 1.5 μg/day, requiring a dedicated polishing step using silica-bound thiol scavenger (Silicycle SiliaMetS Thiol) in flow-through mode at 2 bed volumes per hour. The final active pharmaceutical ingredient monohydrochloride salt is isolated after treatment with anhydrous HCl in ethyl acetate followed by trituration in methyl tert-butyl ether. The 5-chloro substituent is critical: its electron-withdrawing effect lowers the pK_a of the benzothiazole nitrogen to 0.8, preventing protonation at lysosomal pH 5.5, which in turn minimizes phospholipidosis — an adverse effect observed with more basic analogs that accumulate in lysosomal membranes. In cassette dosing pharmacokinetic studies in male Sprague-Dawley rats (n=3 per timepoint, oral gavage 10 mg/kg in 0.5% methylcellulose), the compound achieved a brain/plasma AUC_0-∞ ratio of 2.7 and an unbound brain/plasma partition coefficient (K_p,uu) of 1.4, confirming passive CNS permeation without efflux transporter interaction at human P-glycoprotein (P-gp) in an MDR1-MDCK II monolayer assay (efflux ratio 1.1 at 5 μM). Calculated polar surface area of 45.2 Ų and a clogD_7.4 of 2.9 place the molecule within the CNS multiparameter optimization space (CNS MPO score 5.2). Published PCT patent application WO2013/128028 A1 discloses representative compounds and synthesis from this intermediate class assigned to a major Japanese pharmaceutical innovator. Process-scale hydrogenation of a late-stage nitro intermediate in a Biazzi continuous stirred-tank reactor cascade operating at 50 bar hydrogen pressure and 80°C with 5% Pd/C (Evonik Noblyst P8078, 10% wet loading) achieves >99.7% conversion with 0.02% cumulative des-chloro impurity generated from over-reduction, a selectivity maintained across 6 consecutive catalyst recycles with no observable palladium leaching above the 10 ppm limit per ICH Q3D Elemental Impurities guideline for an oral drug product with a 100 mg maximum daily dose.

A major operational boundary emerges during the hydrodebromination step in the synthesis of the 5-chloro analog: the use of ammonium formate as a transfer hydrogenation agent in methanol at 50°C with 10% Pd/C results in unacceptably rapid dehalogenation of the chlorine substituent when the water content of the solvent exceeds 2.0% by Karl Fischer titration. Production batches must therefore employ methanol dried over 3Å molecular sieves to a moisture content of ≤0.05% and the reaction must be quenched by filtration within 15 minutes of reaching the target conversion of 98.5% as monitored by inline ReactIR at the 737 cm⁻¹ absorption band for the C-Cl stretch. Failure to observe this cutoff results in a des-chloro impurity level exceeding 0.15%, which is above the qualified limit permissible under the Stage 4 Acceptance Criteria of the manufacturing process validation master plan.

Metal Passivation Agent in Chlorinated Solvent Stabilization for Vapour Degreasing Operations

The nitro-derivative of 5-Chloro-2-methyl-1,3-benzothiazole, prepared by mixed-acid nitration at 0–10°C using a 32/68 wt% HNO₃/H₂SO₄ mixture (nitric acid d=1.42, sulfuric acid d=1.84) with 1.05 molar equivalents of nitric acid relative to substrate, functions as a Lewis base inhibitor in 1,1,1-trichloroethane and trichloroethylene vapor degreasing solvent blends. The nitrated benzothiazole adsorbs onto freshly abraded aluminum surfaces — particularly the 2024-T3 aluminum-copper alloy commonly encountered in aerospace structural component cleaning — forming a chemisorbed monolayer that passivates the metal against the autocatalytic dehydrochlorination reaction catalyzed by anhydrous aluminum chloride. In the absence of such a passivator, dissolved aluminum chloride concentrations as low as 50 ppm are sufficient to initiate a runaway dehydrochlorination cascade in trichloroethylene at the boiling point of 87°C, producing corrosive hydrogen chloride and hazardous dichloroacetylene. The inhibitor is dosed into the stabilizer package at 0.05–0.12 wt% relative to the chlorinated solvent, typically in combination with a primary antioxidant (0.1–0.3% 2,6-di-tert-butyl-4-methylphenol, BHT) and an acid scavenger (0.2–0.5% epichlorohydrin or 1,2-epoxybutane). Accelerated stability testing per ASTM D3316-06(2016) — Standard Test Method for Stability of Perchloroethylene with Copper — adapted to trichloroethylene with 2024-T3 aluminum coupons (dimensions 50 mm × 25 mm × 2 mm, abraded with 240-grit silicon carbide paper immediately before immersion) at reflux for 48 hours — must yield an acid acceptance value of ≥0.15% (as NaOH) and no visible etched pits on the metal surface at 20× magnification. Commercial stabilizer pre-blends containing brominated or chlorinated benzothiazoles are supplied by major chlorinated solvent producers under trade designations, with the specific inclusion level calibrated to the expected metal throughput in open-top vapor degreasers with a condensation zone maintained at 4–8°C above the boiling sump. Use of benzothiazole-based inhibitors in methylene chloride-based paint strippers intended for aluminum airframes has been largely supplanted by benzotriazole derivatives due to the lower cost of the latter, though the former retains a niche in formulation variants requiring increased thermal stability in hot-stripping tanks operating at 38°C where the immersion heater surface temperature may locally exceed the solvent flash point of the azeotropic blend.

An operational incompatibility of critical note: the nitro-benzothiazole passivator must not be combined with amine-based alkalinity builders (such as cyclohexylamine or morpholine, frequently added to vapor degreaser stabilizer packages as acid neutralizers at 0.1–0.2%) in the same pre-blended stabilizer concentrate. The interaction results in the formation of a charge-transfer complex with a deep reddish-brown coloration and the concomitant precipitation of an intractable gum that fouls the immersion heater coils and the condensate trough of the degreaser. This incompatibility was identified in a 1997 technical service bulletin from a European solvent manufacturer following complaints of residue formation in Branson ultrasonic degreasers at a Swiss precision watch component plant. Process engineers subsequently implemented a split-dosing procedure: the amine-based buffer components are charged directly to the degreaser sump, while the benzothiazole passivator is introduced via a separate metering pump into the solvent return line from the distillation reclaimer unit, ensuring the two streams never combine at concentrations exceeding 0.05% total actives.

In the specific case of vapor degreasing of titanium alloy Ti-6Al-4V components prior to fluorescent penetrant inspection (FPI) per ASTM E1417/E1417M-21, the passivator concentration must be raised to 0.15–0.20% to counteract the strong Lewis acidity of dissolved titanium tetrachloride, which forms transiently at surface oxide discontinuities where nascent titanium metal is exposed to hot chlorinated solvent. Qualification of the stabilized solvent bath for FPI pre-cleaning requires passing the water-break test within 10 seconds of withdrawal from the vapor zone, with no residual fluorescence under 365 nm UV-A inspection (MIL-I-6866D penetrant sensitivity Level 3 standard titanium panel).

The 2-methyl group remains unfunctionalized in this application; the passivator is loaded in its pristine heterocyclic form. The role of the methyl substituent is to block the 2-position from oxidative attack by dissolved oxygen at the elevated sump temperatures, thereby extending the effective life of the benzothiazole inhibitor in the recirculating solvent inventory of a continuous degreaser from approximately 350 operating hours (for the unsubstituted benzothiazole) to over 800 hours for the methyl analog, based on comparative autoclave aging tests conducted at 100°C under 0.5 MPa pure oxygen with periodic sampling for residual inhibitor concentration via GC-FID.

Published data for the specific rate constant of the surface passivation reaction of 5-chloro-2-methyl-6-nitrobenzothiazole on aluminum 2024-T3 in refluxing trichloroethylene is limited; the Langmuir adsorption isotherm parameters reported in a 2003 volume of Corrosion Science for the analogous 6-nitrobenzothiazole on iron in acidic chloride media cannot be reliably extrapolated to the non-aqueous aluminum system at solvent boiling point. Empirical determination of the minimum effective passivator concentration for a given degreaser geometry and workload remains the standard industrial practice, using the silver mirror test per ASTM D2943-96(2017) as a semiquantitative endpoint.